CL financials
Colgate-Palmolive Company · end-of-day data as of Oct 16, 2026
Colgate-Palmolive Company
$94.11+3.7%
Buy · 21 analystsPT $94.83 +0.8%
CL reported revenue of $5.36B for the quarter ended Jun 30, 2026 (Q2 FY2026), up 4.9% from a year earlier. It posted diluted EPS of $0.86, free cash flow of $867M and a net margin of 12.9%.
Valuation
- P/E37.3x
- P/E vs own+22.3%
- P/E vs sector+59.2%
- FCF yield+5.1%
- Market cap$75.02B
Quarterly results
Q2 FY2026: Revenue +4.9% year over year, free cash flow 16.2% of revenue, operating margin 19.0%.
RevenueFree cash flow
| Q2 FY2026 | Jun 30, 2026 | $5.36B | 0.86 | $867M | 61.5% | 19.0% | 12.9% |
| Q1 FY2026 | Mar 31, 2026 | $5.32B | 0.80 | $609M | 60.6% | 21.7% | 12.1% |
| Q4 FY2025 | Dec 31, 2025 | $5.23B | -0.05 | $1.28B | 60.2% | 20.6% | -0.7% |
| Q3 FY2025 | Sep 30, 2025 | $5.13B | 0.91 | $1.11B | 59.4% | 21.4% | 14.3% |
| Q2 FY2025 | Jun 30, 2025 | $5.11B | 0.91 | $776M | 60.1% | 21.1% | 14.5% |
| Q1 FY2025 | Mar 31, 2025 | $4.91B | 0.85 | $476M | 60.8% | 21.9% | 14.1% |
| Q4 FY2024 | Dec 31, 2024 | $4.94B | 0.90 | $1.08B | 60.3% | 22.0% | 14.9% |
| Q3 FY2024 | Sep 30, 2024 | $5.03B | 0.90 | $1.03B | 61.1% | 22.1% | 14.6% |
| Q2 FY2024 | Jun 30, 2024 | $5.06B | 0.89 | $873M | 60.7% | 22.9% | 14.5% |
| Q1 FY2024 | Mar 31, 2024 | $5.07B | 0.83 | $555M | 59.9% | 23.2% | 13.5% |
| Q4 FY2023 | Dec 31, 2023 | $4.95B | 0.87 | $939M | 59.5% | 23.0% | 14.5% |
| Q3 FY2023 | Sep 30, 2023 | $4.92B | 0.86 | $991M | 58.7% | 21.6% | 14.4% |